PRAA(PRAA)
PRAA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.22B | $1.22B |
| Low | $1.17B | $1.17B |
| High | $1.26B | $1.26B |
| EBITDA Avg | $155M | $154M |
| Low | $148M | $148M |
| High | $160M | $160M |
| EBIT Avg | $137M | $137M |
| Low | $131M | $131M |
| High | $142M | $142M |
| Net Income Avg | $103M | $117M |
| Low | $92M | $102M |
| High | $105M | $119M |
| EPS Avg | $2.52 | $2.83 |
| Low | $2.35 | $2.60 |
| High | $2.67 | $3.04 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $302M | $304M | $302M | $304M | $305M | $308M |
| Low | $284M | $277M | $284M | $286M | $287M | $290M |
| High | $316M | $325M | $317M | $318M | $320M | $323M |
| EBITDA Avg | $38M | $39M | $38M | $38M | $39M | $39M |
| Low | $36M | $35M | $36M | $36M | $36M | $37M |
| High | $40M | $41M | $40M | $40M | $41M | $41M |
| EBIT Avg | $34M | $34M | $34M | $34M | $34M | $35M |
| Low | $32M | $31M | $32M | $32M | $32M | $33M |
| High | $36M | $37M | $36M | $36M | $36M | $36M |
| Net Income Avg | $23M | $26M | $25M | $25M | $28M | $31M |
| Low | $21M | $18M | $23M | $23M | $26M | $29M |
| High | $24M | $33M | $27M | $26M | $29M | $33M |
| EPS Avg | $0.59 | $0.67 | $0.66 | $0.65 | $0.72 | $0.81 |
| Low | $0.55 | $0.47 | $0.61 | $0.60 | $0.67 | $0.75 |
| High | $0.63 | $0.87 | $0.70 | $0.69 | $0.76 | $0.86 |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |